Clinical Efficacy and Safety of a Novel Antifungal, Fosmanogepix, in Patients with Candidemia Caused by Candida auris: Results from a Phase 2 Trial

Jose A. Vazquez, Peter G. Pappas, Kenneth Boffard, Fathima Paruk, Paul A. Bien, Margaret Tawadrous, Eric Ople, Pamela Wedel, Iwona Oborska, Michael R. Hodges

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical Efficacy and Safety of a Novel Antifungal, Fosmanogepix, in Patients with Candidemia Caused by Candida auris: Results from a Phase 2 Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences